The effect of ticagrelor on the QT interval in male volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Moxifloxacin; Ticagrelor
- Indications Acute coronary syndromes; Bacterial infections; Embolism and thrombosis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 05 Nov 2010 New trial record.